Overview
Harumitsu Suzuki practices in Wakayama, Japan. Suzuki is rated as an Experienced expert by MediFind in the treatment of COVID-19. Their top areas of expertise are Prognathism, COVID-19, Severe Acute Respiratory Syndrome (SARS), CACH Syndrome, and Osteotomy.
Their clinical research consists of co-authoring 18 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of COVID-19.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CACH SyndromeSuzuki isExperienced. Learn about CACH Syndrome.
- CalcinosisSuzuki isExperienced. Learn about Calcinosis.
- COVID-19Suzuki isExperienced. Learn about COVID-19.
- OsteotomySuzuki isExperienced. Learn about Osteotomy.
- PrognathismSuzuki isExperienced. Learn about Prognathism.
- Severe Acute Respiratory Syndrome (SARS)